Flexion Therapeutics

As a highly focused specialty pharmaceutical team, our goal is to cost effectively develop and commercialize novel therapies that will provide safe, substantial and sustained pain relief to the sufferers of musculoskeletal (MSK) diseases, the first of which is OA. We focus on product candidates that have the potential to provide long-lasting analgesia locally while avoiding systemic side effects. We also aim to:
Type
Public
HQ
Burlington, US
Founded
2007
Employees
48 (est)
Flexion Therapeutics was founded in 2007 and is headquartered in Burlington, US

Key People at Flexion Therapeutics

Mike Clayman

Mike Clayman

Chief Executive Officer & Co-Founder
Steve Dykstra

Steve Dykstra

Vice President of CMC
Lisa Davidson

Lisa Davidson

Vice President, Finance and Administration
Neil Bodick

Neil Bodick

Chief Medical Officer & Co-Founder
Anjali Kumar

Anjali Kumar

Vice President, Preclinical Research and Development
Art Fratamico

Art Fratamico

Chief Business Officer

Flexion Therapeutics Locations

Burlington, US

Flexion Therapeutics Metrics

Flexion Therapeutics Summary

Market capitalization

$520 M

Closing share price

$18.4
Flexion Therapeutics's current market capitalization is $520 M.

Flexion Therapeutics Market Value History

We estimate that Flexion Therapeutics's current employees are approximately 25% female and 75% male.

Flexion Therapeutics Online Presence

Flexion Therapeutics News

Flexion Therapeutics Company Life

You may also be interested in